Drug and device firms paid $6.5B to care providers

From research dollars to free lunches and junkets, drug and medical device companies paid doctors and leading hospitals nearly $6.5 billion last year, according to government data posted Tuesday.

The latest update to the Open Payments database is part of an ongoing effort to highlight potential conflicts of interest in medicine. Unlike last year's initial version of the database, this one is much easier to use for consumers interested in looking up their own doctors.

Of the total payments, $3.2 billion represented research funding, about $2.6 billion was for miscellaneous items and about $700 million represented investments and ownership stakes. Drug companies often recruit doctors to help with clinical trials and other research on particular medications.

About 80 percent of the total dollars went to doctors, whose prescribing decisions affect the fortunes of pharmaceutical and manufacturers. Nearly 610,000 received payments, as well as some 1,100 teaching hospitals.

Consumer groups say it's a step toward transparency. Doctors, hospitals and industry worry that context will be lost. The Open Payments program was created under President Barack Obama's .

Explore further

Gov't to reveal drug company payments to doctors

More information: Open Payments database: openpaymentsdata.cms.gov/

© 2015 The Associated Press. All rights reserved.

Citation: Drug and device firms paid $6.5B to care providers (2015, June 30) retrieved 24 January 2021 from https://medicalxpress.com/news/2015-06-drug-device-firms-paid-65b.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments